Journal Scans
Risk of Death From Prostate Cancer After Brachytherapy Alone or With Radiation, Androgen Suppression Therapy, or Both in Men With High-Risk Disease
Trimodality Therapy Decreases Mortality in High-Risk Prostate Cancer Patients
AV D'Amico, BJ Moran, MH Braccioforte, D Dosoretz, S Salenius, M Katin, R Ross, M-H Chen
20090613
2009 Jul 13
J Clin Oncol
Risk of Death From Prostate Cancer After Brachytherapy Alone or With Radiation, Androgen Suppression Therapy, or Both in Men With High-Risk Disease
J Clin Oncol. 2009 Jul 13; Epub ahead of print, AV D'Amico, BJ Moran, MH Braccioforte, D Dosoretz, S Salenius, M Katin, R Ross, M-H Chen
TAKE-HOME MESSAGE
Abstract
SUMMARY
OncologySTAT Editorial Team
Use of prostate brachytherapy as part of multimodality treatment in men with high-risk prostate cancer has not been well studied. Therefore, various brachytherapy treatment approaches are used in both community and academic settings. These approaches include brachytherapy alone or brachytherapy combined with supplemental androgen suppression therapy (AST) or external beam radiation therapy (EBRT). This study by D’Amico et al was designed to determine which treatment approach most improves prostate...
